Severe open angle glaucoma in hereditary hemorrhagic telangiectasia

By  

Clinical Case Reports, Vol. 3, Iss. 9, 2015-09 ,pp. : 725-727

John Wiley & Sons Inc

Access to resources Recommend Favorite

Optimal Management of Facial Telangiectasia

By Mitchel P. Goldman  

American Journal of Clinical Dermatology, Vol. 5, Iss. 6, 2004-01 ,pp. : 423-434

Adis International

Access to resources Recommend Favorite

Safety and Efficacy of Subcutaneously Administered Efalizumab in Adults with Moderate-to-Severe Hand and Foot Psoriasis: An Open-Label Study

By Varma Rajat   Cafardi Jennifer A.   Cantrell Wendy   Elmets Craig  

American Journal of Clinical Dermatology, Vol. 9, Iss. 2, 2008-01 ,pp. : 105-109

Adis International

Access to resources Recommend Favorite

Anti-VEGF Treatment of Glaucoma

By  

Current Drug Therapy, Vol. 7, Iss. 2, 2012-06 ,pp. : 126-130

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of efonidipine, an L- and T-Type dual calcium channel blocker, on heart rate and blood pressure in patients with mild to severe hypertension: an uncontrolled, open-label pilot study

By Shimizu M.   Ogawa K.   Sasaki H.   Uehara Y.   Otsuka Y.   Okumura H.   Kusaka M.   Hasuda T.   Yamada T.   Mochizuki S.  

Current Therapeutic Research, Vol. 64, Iss. 9, 2003-11 ,pp. : 707-714

Elsevier

Access to resources Recommend Favorite